Atlas Trials

A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects

Clinical trial NCT05109832 · COMPLETED

Trial details

NCT number
NCT05109832
Sponsor
Impact Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2021-10-09
Primary completion
2021-12-06
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.